2018
DOI: 10.1007/s10549-018-4868-x
|View full text |Cite
|
Sign up to set email alerts
|

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

Abstract: In the absence of high-quality data comparing vascular access strategies, randomised, adequately powered, prospective studies would be required to help inform clinical practice and reduce variation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
40
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(45 citation statements)
references
References 26 publications
3
40
0
Order By: Relevance
“…1,4,5 With the development of PICCs, many studies have compared PICCs with other VADs for the purpose of selecting the most appropriate VAD in different clinical scenarios. [6][7][8] Most of the existing studies have focused on the complications related to catheters, the success rate of insertion, and catheter dwell days between PICCs and other VADs. [6][7][8] Several systematic reviews 6,8 indicated that PICCs were associated with more complications during maintenance compared with CVCs and PORTs.…”
Section: Introductionmentioning
confidence: 99%
“…1,4,5 With the development of PICCs, many studies have compared PICCs with other VADs for the purpose of selecting the most appropriate VAD in different clinical scenarios. [6][7][8] Most of the existing studies have focused on the complications related to catheters, the success rate of insertion, and catheter dwell days between PICCs and other VADs. [6][7][8] Several systematic reviews 6,8 indicated that PICCs were associated with more complications during maintenance compared with CVCs and PORTs.…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10][11][12] However, several systematic reviews have raised questions regarding the appropriateness of PICCs in patients with cancer due to the higher incidence of CR-DVT. [13][14][15][16]…”
Section: Long-term Central Venous Catheters Todaymentioning
confidence: 99%
“…A systematic review by Robinson et al regarding patients with breast cancer, was published in 2018. 15 This review identified three papers using questionnaires to examine quality-of-life in patients with breast cancer and a vascular access device. The authors concluded that the use of a PORT is generally well accepted.…”
Section: Patient Perceptionmentioning
confidence: 99%
“…Totally implanted venous access port (TIVAP) has been established as an effective and safe procedure for cancer patients, which could be applied to chemotherapy infusion, blood sampling, as well as nutrition supply [1,2]. TIVAPs have manifested evident superiority with fewer complications and more convenient catheter management compared with peripherally inserted central catheter or any other externally tunneled catheter [3]. In recent years, TIVAPs have been widely used in patients with malignancies needing to receive a long-term catheterization.…”
Section: Introductionmentioning
confidence: 99%